Charles M. Winter serves as Chief Technical Officer at Janux Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Charles M. Winter has executed 3 insider transactions totaling $33.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 2, 2026 involved receiving (via award) 100,100 shares valued at $0.
Charles M. Winter currently holds 100,100 shares of Janux Therapeutics, Inc. (JANX), valued at approximately $0. This represents their equity stake as Chief Technical Officer.
Based on SEC Form 4 filings, Charles M. Winter has been a net seller of JANX stock. They have purchased $0 and sold $33.0K worth of shares.
Charles M. Winter's most recent insider trade was on Jan 2, 2026, when they sold 100,100 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jan 2, 2026 | JANX | $33.0K | Sale | 2,401 | $13.73 | Discretionary |